Loading...

Mclaren, Christine Ellen

Title(s)Professor, Medicine
Phone(949) 824-4007
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Modulation of Iron Overload by Hepcidin and Erythroferrone
    NIH/NHLBI R21HL145232Sep 15, 2018 - Aug 31, 2020
    Role: Principal Investigator
    Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y Homozygotes
    NIH/NIDDK R24DK099846Sep 1, 2014 - Jun 30, 2017
    Role: Principal Investigator
    Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y Homozygotes
    NIH/NIDDK R24DK093433Sep 15, 2011 - Aug 31, 2014
    Role: Principal Investigator
    Iron Status: A Pathway Analysis in Multiple Ethnicities
    NIH/NHLBI R01HL083328Aug 14, 2006 - Jul 31, 2012
    Role: Principal Investigator
    IRON OVERLOAD AND HEREDITARY HEMOCHROMATOSIS STUDY
    NIH/NHLBI N01HC005190Jan 31, 2000 - Jan 31, 2005
    Role: Principal Investigator
    STATISTICAL BASIS FOR HEMOCHROMATOSIS SCREENING
    NIH/NHLBI R15HL058203Jul 15, 1997 - Jun 30, 2000
    Role: Principal Investigator
    GENERALIZED CHI-SQUARED TEST FOR COMPARING DISTRIBUTIONS
    NIH/FIC F06TW002117Nov 27, 1995
    Role: Principal Investigator
    SEQUENTIAL ANALYSIS OF HEMATOLOGIC MEASUREMENTS
    NIH/NHLBI R15HL048349Jun 1, 1992 - May 31, 1995
    Role: Principal Investigator
    MIXTURES OF RED BLOOD CELL VOLUME DISTRIBUTIONS
    NIH/NHLBI R15HL042681Apr 15, 1989 - Mar 31, 1992
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bosschaart N, Leproux A, Abdalsalam O, Chen WP, McLaren CE, Tromberg BJ, O'Sullivan TD. Diffuse optical spectroscopic imaging for the investigation of human lactation physiology: a case study on mammary involution. J Biomed Opt. 2019 05; 24(5):1-8. PMID: 31124346.
      View in: PubMed
    2. McLaren CE, Chen WP, Bertalli NA, Delatycki MB, Giles GG, English DR, Hopper JL, Allen KJ, Gurrin LC. Bivariate mixture models for the joint distribution of repeated serum ferritin and transferrin saturation measured 12 years apart in a cohort of healthy middle-aged Australians. PLoS One. 2019; 14(3):e0214196. PMID: 30913256.
      View in: PubMed
    3. Barton JC, McLaren CE, Chen WP, Ramm GA, Anderson GJ, Powell LW, Subramaniam VN, Adams PC, Phatak PD, Gurrin LC, Phillips JD, Parker CJ, Emond MJ, McLaren GD. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes. Ann Hepatol. 2018 Aug 24; 17(5):871-879. PMID: 30145563.
      View in: PubMed
    4. Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Loréal O. Haemochromatosis. Nat Rev Dis Primers. 2018 04 05; 4:18016. PMID: 29620054.
      View in: PubMed
    5. Lam JH, O'Sullivan TD, Park TS, Choi JH, Warren RV, Chen WP, McLaren CE, Cancio LC, Batchinsky AI, Tromberg BJ. Non-invasive Dual-Channel Broadband Diffuse Optical Spectroscopy of Massive Hemorrhage and Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in Swine. Mil Med. 2018 03 01; 183(suppl_1):150-156. PMID: 29635570.
      View in: PubMed
    6. Khan AA, Srivastava R, Chentoufi AA, Kritzer E, Chilukuri S, Garg S, Yu DC, Vahed H, Huang L, Syed SA, Furness JN, Tran TT, Anthony NB, McLaren CE, Sidney J, Sette A, Noelle RJ, BenMohamed L. Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease. J Immunol. 2017 07 01; 199(1):186-203. PMID: 28539429.
      View in: PubMed
    7. McLaren CE, Chen WP, O'Sullivan TD, Gillen DL, Su MY, Chen JH, Tromberg BJ. Sample size and power determination when limited preliminary information is available. BMC Med Res Methodol. 2017 Apr 26; 17(1):75. PMID: 28446127.
      View in: PubMed
    8. Warne CD, Zaloumis SG, Bertalli NA, Delatycki MB, Nicoll AJ, McLaren CE, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, Powell LW, Allen KJ, Gurrin LC. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women. J Gastroenterol Hepatol. 2017 Apr; 32(4):797-802. PMID: 27784128.
      View in: PubMed
    9. Aminololama-Shakeri S, Flowers CI, McLaren CE, Wisner DJ, de Guzman J, Campbell JE, Bassett LW, Ojeda-Fournier H, Gerlach K, Hargreaves J, Elson SL, Retallack H, Joe BN, Feig SA, Wells CJ. Can Radiologists Predict the Presence of Ductal Carcinoma In Situ and Invasive Breast Cancer? AJR Am J Roentgenol. 2017 Apr; 208(4):933-939. PMID: 28199152.
      View in: PubMed
    10. McLaren GD, Barton JC, Ramm GA, Emond MJ, Subramaniam VN, Phatak PD, Adams PC, Powell LW, Gurrin LC, Anderson GJ, McLaren CE. Reply. Hepatology. 2017 03; 65(3):1072-1073. PMID: 28010035.
      View in: PubMed
    11. Barton JC, Chen WP, Emond MJ, Phatak PD, Subramaniam VN, Adams PC, Gurrin LC, Anderson GJ, Ramm GA, Powell LW, Allen KJ, Phillips JD, Parker CJ, McLaren GD, McLaren CE. GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. Blood Cells Mol Dis. 2017 03; 63:15-20. PMID: 27936396.
      View in: PubMed
    12. Huang JY, Samarasena JB, Tsujino T, Lee J, Hu KQ, McLaren CE, Chen WP, Chang KJ. EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc. 2017 May; 85(5):996-1001. PMID: 27693644.
      View in: PubMed
    13. Farrell CP, Overbey JR, Naik H, Nance D, McLaren GD, McLaren CE, Zhou L, Desnick RJ, Parker CJ, Phillips JD. The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda. PLoS One. 2016; 11(9):e0163322. PMID: 27661980.
      View in: PubMed
    14. Leproux A, Kim YM, Min JW, McLaren CE, Chen WP, O'Sullivan TD, Lee SH, Chung PS, Tromberg BJ. Differential diagnosis of breast masses in South Korean premenopausal women using diffuse optical spectroscopic imaging. J Biomed Opt. 2016 07 01; 21(7):74001. PMID: 27436049.
      View in: PubMed
    15. McLaren CE, Barton JC, Subramaniam VN, Ramm GA, Phatak PD, Emond MJ, Gurrin LC, Adams PC, Powell LW, Anderson GJ, McLaren GD. Reply. Hepatology. 2016 06; 63(6):2058-60. PMID: 26845080.
      View in: PubMed
    16. McLaren CE, Barton JC, Phatak PD, Emond MJ, Subramaniam VN, Gurrin LC, Adams PC, Powell LW, Ramm GA, Anderson GJ, McLaren GD. Reply. Hepatology. 2016 06; 63(6):2056-7. PMID: 26417986.
      View in: PubMed
    17. McLaren CE, Emond MJ, Subramaniam VN, Phatak PD, Barton JC, Adams PC, Powell LW, Gurrin LC, Ramm GA, Anderson GJ, McLaren GD. Reply: To PMID 25605615. Hepatology. 2015 Dec; 62(6):1918-9. PMID: 25914125.
      View in: PubMed
    18. Chen JH, Chan S, Tang YT, Hon JS, Tseng PC, Cheriyan AT, Shah NR, Yeh DC, Lee SK, Chen WP, McLaren CE, Su MY. Impact of positional difference on the measurement of breast density using MRI. Med Phys. 2015 May; 42(5):2268-75. PMID: 25979021.
      View in: PubMed
    19. Zaloumis SG, Allen KJ, Bertalli NA, Turkovic L, Delatycki MB, Nicoll AJ, McLaren CE, English DR, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, Powell LW, Gurrin LC. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study. J Gastroenterol Hepatol. 2015 Apr; 30(4):719-25. PMID: 25311314.
      View in: PubMed
    20. McLaren CE, Emond MJ, Subramaniam VN, Phatak PD, Barton JC, Adams PC, Goh JB, McDonald CJ, Powell LW, Gurrin LC, Allen KJ, Nickerson DA, Louie T, Ramm GA, Anderson GJ, McLaren GD. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload. Hepatology. 2015 Aug; 62(2):429-39. PMID: 25605615.
      View in: PubMed
    21. Billheimer D, Gerner EW, McLaren CE, LaFleur B. Combined benefit of prediction and treatment: a criterion for evaluating clinical prediction models. Cancer Inform. 2014; 13(Suppl 2):93-103. PMID: 25336898.
      View in: PubMed
    22. Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL. A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology. Cancer Prev Res (Phila). 2014 May; 7(5):496-504. PMID: 24614012.
      View in: PubMed
    23. Jia Z, Lilly MB, Koziol JA, Chen X, Xia XQ, Wang Y, Skarecky D, Sutton M, Sawyers A, Ruckle H, Carpenter PM, Wang-Rodriguez J, Jiang J, Deng M, Pan C, Zhu JG, McLaren CE, Gurley MJ, Lee C, McClelland M, Ahlering T, Kattan MW, Mercola D. Generation of "virtual" control groups for single arm prostate cancer adjuvant trials. PLoS One. 2014; 9(1):e85010. PMID: 24465467.
      View in: PubMed
    24. Mainous AG, Wright RU, Hulihan MM, Twal WO, McLaren CE, Diaz VA, McLaren GD, Argraves WS, Grant AM. Elevated transferrin saturation, health-related quality of life and telomere length. Biometals. 2014 Feb; 27(1):135-41. PMID: 24337410.
      View in: PubMed
    25. Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen WP, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY. Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol. 2014 Feb; 109(2):158-67. PMID: 24166728.
      View in: PubMed
    26. Koh CY, Demirjian AN, Chen WP, McLaren CE, Imagawa DK. Validation of revised American Joint Committee on Cancer staging for gallbladder cancer based on a single institution experience. Am Surg. 2013 Oct; 79(10):1045-9. PMID: 24160796.
      View in: PubMed
    27. Davis BH, McLaren CE, Carcio AJ, Wong L, Hedley BD, Keeney M, Curtis A, Culp NB. Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical method. Cytometry B Clin Cytom. 2013 Sep-Oct; 84(5):329-37. PMID: 24022856.
      View in: PubMed
    28. Chen JH, Pan WF, Kao J, Lu J, Chen LK, Kuo CC, Chang CK, Chen WP, McLaren CE, Bahri S, Mehta RS, Su MY. Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR Biomed. 2013 Dec; 26(12):1705-13. PMID: 23940080.
      View in: PubMed
    29. Davis BH, McLaren CE, Carcio AJ, Wong L, Hedley BD, Keeney M, Curtis A, Culp NB. Determination of optimal replicate number for validation of imprecision using fluorescence cell based assays: Proposed practical method. Cytometry B Clin Cytom. 2013 Jul 19. PMID: 23873644.
      View in: PubMed
    30. Adams PC, McLaren CE, Speechley M, McLaren GD, Barton JC, Eckfeldt JH. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L. Can J Gastroenterol. 2013 Jul; 27(7):390-2. PMID: 23862168.
      View in: PubMed
    31. Mainous AG, Wright RU, Hulihan MM, Twal WO, McLaren CE, Diaz VA, McLaren GD, Argraves WS, Grant AM. Telomere length and elevated iron: the influence of phenotype and HFE genotype. Am J Hematol. 2013 Jun; 88(6):492-6. PMID: 23512844.
      View in: PubMed
    32. Chen JH, Chen WP, Chan S, Yeh DC, Su MY, McLaren CE. Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle. Ann Oncol. 2013 Sep; 24(9):2329-35. PMID: 23661294.
      View in: PubMed
    33. O'Sullivan TD, Leproux A, Chen JH, Bahri S, Matlock A, Roblyer D, McLaren CE, Chen WP, Cerussi AE, Su MY, Tromberg BJ. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res. 2013 Feb 22; 15(1):R14. PMID: 23433249.
      View in: PubMed
    34. Murray JA, McLachlan S, Adams PC, Eckfeldt JH, Garner CP, Vulpe CD, Gordeuk VR, Brantner T, Leiendecker-Foster C, Killeen AA, Acton RT, Barcellos LF, Nickerson DA, Beckman KB, McLaren GD, McLaren CE. Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians. Clin Gastroenterol Hepatol. 2013 Jul; 11(7):808-14. PMID: 23416278.
      View in: PubMed
    35. Jia Z, Wang Y, Hu Y, McLaren C, Yu Y, Ye K, Xia XQ, Koziol JA, Lernhardt W, McClelland M, Mercola D. A sample selection strategy to boost the statistical power of signature detection in cancer expression profile studies. Anticancer Agents Med Chem. 2013 Feb; 13(2):203-11. PMID: 22934703.
      View in: PubMed
    36. Raj KP, Zell JA, Rock CL, McLaren CE, Zoumas-Morse C, Gerner EW, Meyskens FL. Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Br J Cancer. 2013 Feb 19; 108(3):512-8. PMID: 23340449.
      View in: PubMed
    37. Zell JA, Lin BS, Madson N, McLaren CE, Gerner EW, Meyskens FL. Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas. Cancer Causes Control. 2012 Oct; 23(10):1739-44. PMID: 22907422.
      View in: PubMed
    38. Pinn-Bingham M, Puthawala AA, Syed AM, Sharma A, Disaia P, Berman M, Tewari KS, Randall-Whitis L, Mahmood U, Ramsinghani N, Kuo J, Chen WP, McLaren CE. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):714-20. PMID: 22763030.
      View in: PubMed
    39. McLaren CE, McLachlan S, Garner CP, Vulpe CD, Gordeuk VR, Eckfeldt JH, Adams PC, Acton RT, Murray JA, Leiendecker-Foster C, Snively BM, Barcellos LF, Cook JD, McLaren GD. Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations. PLoS One. 2012; 7(6):e38339. PMID: 22761678.
      View in: PubMed
    40. Gordeuk VR, Lovato L, Barton J, Vitolins M, McLaren G, Acton R, McLaren C, Harris E, Speechley M, Eckfeldt JH, Diaz S, Sholinsky P, Adams P. Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation. Can J Gastroenterol. 2012 Jun; 26(6):345-9. PMID: 22720276.
      View in: PubMed
    41. Adams PC, Speechley M, Barton JC, McLaren CE, McLaren GD, Eckfeldt JH. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology. 2012 Jun; 55(6):1722-6. PMID: 22183642.
      View in: PubMed
    42. Roblyer D, Ueda S, Cerussi A, Tanamai W, Durkin A, Mehta R, Hsiang D, Butler JA, McLaren C, Chen WP, Tromberg B. Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment. Proc Natl Acad Sci U S A. 2011 Aug 30; 108(35):14626-31. PMID: 21852577.
      View in: PubMed
    43. Mainous AG, Diaz VA, Everett CJ, Knoll ME, Hulihan MM, Grant AM, McLaren CE, McLaren GD. IRon Overload screeNing tool (IRON): development of a tool to guide screening in primary care. Am J Hematol. 2011 Sep; 86(9):733-7. PMID: 21800355.
      View in: PubMed
    44. Bertalli NA, Allen KJ, McLaren CE, Turkovic L, Osborne NJ, Constantine CC, Delatycki MB, English DR, Giles GG, Hopper JL, Anderson GJ, Olynyk JK, Powell LW, Gurrin LC. A comparison of self-reported and record-linked blood donation history in an Australian cohort. Transfusion. 2011 Oct; 51(10):2189-98. PMID: 21985049.
      View in: PubMed
    45. McLaren CE, Garner CP, Constantine CC, McLachlan S, Vulpe CD, Snively BM, Gordeuk VR, Nickerson DA, Cook JD, Leiendecker-Foster C, Beckman KB, Eckfeldt JH, Barcellos LF, Murray JA, Adams PC, Acton RT, Killeen AA, McLaren GD. Genome-wide association study identifies genetic loci associated with iron deficiency. PLoS One. 2011 Mar 31; 6(3):e17390. PMID: 21483845.
      View in: PubMed
    46. Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, Brenner DE. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011 Mar; 4(3):354-64. PMID: 21372035.
      View in: PubMed
    47. Meyskens FL, McLaren CE. Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy? J Natl Cancer Inst. 2010 Dec 15; 102(24):1815-7. PMID: 21115881.
      View in: PubMed
    48. Garcia AM, McLaren CE, Meyskens FL. Melanoma: is hair the root of the problem? Pigment Cell Melanoma Res. 2011 Feb; 24(1):110-8. PMID: 20880199.
      View in: PubMed
    49. Allen KJ, Bertalli NA, Osborne NJ, Constantine CC, Delatycki MB, Nisselle AE, Nicoll AJ, Gertig DM, McLaren CE, Giles GG, Hopper JL, Anderson GJ, Olynyk JK, Powell LW, Gurrin LC. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology. 2010 Sep; 52(3):925-33. PMID: 20583211.
      View in: PubMed
    50. Zell JA, McLaren CE, Chen WP, Thompson PA, Gerner EW, Meyskens FL. Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J Natl Cancer Inst. 2010 Oct 06; 102(19):1513-6. PMID: 20798393.
      View in: PubMed
    51. Chang KJ, Erickson RA, Chak A, Lightdale C, Chen YK, Binmoeller KF, Albers GC, Chen WP, McLaren CE, Sivak MV, Lee JG, Isenberg GA, Wong RC. EUS compared with endoscopy plus transabdominal US in the initial diagnostic evaluation of patients with upper abdominal pain. Gastrointest Endosc. 2010 Nov; 72(5):967-74. PMID: 20650452.
      View in: PubMed
    52. Thompson PA, Wertheim BC, Zell JA, Chen WP, McLaren CE, LaFleur BJ, Meyskens FL, Gerner EW. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma. Gastroenterology. 2010 Sep; 139(3):797-805, 805.e1. PMID: 20538001.
      View in: PubMed
    53. Nie K, Su MY, Chau MK, Chan S, Nguyen H, Tseng T, Huang Y, McLaren CE, Nalcioglu O, Chen JH. Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys. 2010 Jun; 37(6):2770-6. PMID: 20632587.
      View in: PubMed
    54. Osborne NJ, Gurrin LC, Allen KJ, Constantine CC, Delatycki MB, McLaren CE, Gertig DM, Anderson GJ, Southey MC, Olynyk JK, Powell LW, Hopper JL, Giles GG, English DR. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology. 2010 Apr; 51(4):1311-8. PMID: 20099304.
      View in: PubMed
    55. Acton RT, Barton JC, Leiendecker-Foster C, Zaun C, McLaren CE, Eckfeldt JH. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants. Blood Cells Mol Dis. 2010 Apr 15; 44(4):252-6. PMID: 20178892.
      View in: PubMed
    56. McLaren CE, Barton JC, Eckfeldt JH, McLaren GD, Acton RT, Adams PC, Henkin LF, Gordeuk VR, Vulpe CD, Harris EL, Harrison BW, Reiss JA, Snively BM. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study. Am J Hematol. 2010 Feb; 85(2):101-5. PMID: 20095037.
      View in: PubMed
    57. Chorney JM, Torrey C, Blount R, McLaren CE, Chen WP, Kain ZN. Healthcare provider and parent behavior and children's coping and distress at anesthesia induction. Anesthesiology. 2009 Dec; 111(6):1290-6. PMID: 19934874.
      View in: PubMed
    58. Adams P, Barton JC, McLaren GD, Acton RT, Speechley M, McLaren CE, Reboussin DM, Leiendecker-Foster C, Harris EL, Snively BM, Vogt T, Sholinsky P, Thomson E, Dawkins FW, Gordeuk VR, Eckfeldt JH. Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study. Can J Gastroenterol. 2009 Nov; 23(11):769-72. PMID: 19893773.
      View in: PubMed
    59. Constantine CC, Anderson GJ, Vulpe CD, McLaren CE, Bahlo M, Yeap HL, Gertig DM, Osborne NJ, Bertalli NA, Beckman KB, Chen V, Matak P, McKie AT, Delatycki MB, Olynyk JK, English DR, Southey MC, Giles GG, Hopper JL, Allen KJ, Gurrin LC. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol. 2009 Oct; 147(1):140-9. PMID: 19673882.
      View in: PubMed
    60. Gurrin LC, Bertalli NA, Dalton GW, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, Delatycki MB, Nicoll AJ, Southey MC, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, Powell LW, Allen KJ. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology. 2009 Jul; 50(1):94-101. PMID: 19554541.
      View in: PubMed
    61. McLaren CE, Chen WP, Nie K, Su MY. Prediction of malignant breast lesions from MRI features: a comparison of artificial neural network and logistic regression techniques. Acad Radiol. 2009 Jul; 16(7):842-51. PMID: 19409817.
      View in: PubMed
    62. Carpenter PM, Chen WP, Mendez A, McLaren CE, Su MY. Angiogenesis in the progression of breast ductal proliferations. Int J Surg Pathol. 2011 Jun; 19(3):335-41. PMID: 19403546.
      View in: PubMed
    63. Zell JA, Pelot D, Chen WP, McLaren CE, Gerner EW, Meyskens FL. Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila). 2009 Mar; 2(3):209-12. PMID: 19258540.
      View in: PubMed
    64. Wang X, Leiendecker-Foster C, Acton RT, Barton JC, McLaren CE, McLaren GD, Gordeuk VR, Eckfeldt JH. Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis. 2009 Mar-Apr; 42(2):150-4. PMID: 19176287.
      View in: PubMed
    65. McLaren CE, Fujikawa-Brooks S, Chen WP, Gillen DL, Pelot D, Gerner EW, Meyskens FL. Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila). 2008 Dec; 1(7):514-21. PMID: 19139001.
      View in: PubMed
    66. McLaren GD, McLaren CE, Adams PC, Barton JC, Reboussin DM, Gordeuk VR, Acton RT, Harris EL, Speechley MR, Sholinsky P, Dawkins FW, Snively BM, Vogt TM, Eckfeldt JH. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol. 2008 Nov; 22(11):923-30. PMID: 19018338.
      View in: PubMed
    67. Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, Delatycki MB, Southey MC, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, Powell LW, Allen KJ. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology. 2008 Dec; 135(6):1945-52. PMID: 18848943.
      View in: PubMed
    68. Gordeuk VR, Reboussin DM, McLaren CE, Barton JC, Acton RT, McLaren GD, Harris EL, Reiss JA, Adams PC, Speechley M, Phatak PD, Sholinsky P, Eckfeldt JH, Chen WP, Passmore L, Dawkins FW. Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol. 2008 Aug; 83(8):618-26. PMID: 18429050.
      View in: PubMed
    69. Adams PC, Reboussin DM, Barton JC, Acton RT, Speechley M, Leiendecker-Foster C, Meenan R, Passmore L, McLaren CE, McLaren GD, Gordeuk V, Dawkins F, Eckfeldt JH. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study. Int J Lab Hematol. 2008 Aug; 30(4):300-5. PMID: 18665827.
      View in: PubMed
    70. Acton RT, Barton JC, Passmore LV, Adams PC, McLaren GD, Leiendecker-Foster C, Speechley MR, Harris EL, Castro O, Reiss JA, Snively BM, Harrison BW, McLaren CE. Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol. 2008 Aug; 6(8):934-8. PMID: 18585964.
      View in: PubMed
    71. Wong BJ, Karimi K, Devcic Z, McLaren CE, Chen WP. Evolving attractive faces using morphing technology and a genetic algorithm: a new approach to determining ideal facial aesthetics. Laryngoscope. 2008 Jun; 118(6):962-74. PMID: 18401273.
      View in: PubMed
    72. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila). 2008 Jun; 1(1):32-8. PMID: 18841250.
      View in: PubMed
    73. Constantine CC, Gurrin LC, McLaren CE, Bahlo M, Anderson GJ, Vulpe CD, Forrest SM, Allen KJ, Gertig DM. SNP selection for genes of iron metabolism in a study of genetic modifiers of hemochromatosis. BMC Med Genet. 2008 Mar 20; 9:18. PMID: 18366708.
      View in: PubMed
    74. Simoneau AR, Gerner EW, Nagle R, Ziogas A, Fujikawa-Brooks S, Yerushalmi H, Ahlering TE, Lieberman R, McLaren CE, Anton-Culver H, Meyskens FL. The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):292-9. PMID: 18268112.
      View in: PubMed
    75. Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, Eckfeldt JH, McLaren CE, Reiss JA, McLaren GD, Reboussin DM, Gordeuk VR, Speechley MR, Press RD, Dawkins FW. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening. Am J Hematol. 2008 Feb; 83(2):126-32. PMID: 17726683.
      View in: PubMed
    76. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008 Jan 17; 358(3):221-30. PMID: 18199861.
      View in: PubMed
    77. McLaren CE, Gordeuk VR, Chen WP, Barton JC, Acton RT, Speechley M, Castro O, Adams PC, Snively BM, Harris EL, Reboussin DM, McLachlan GJ, Bean R. Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Transl Res. 2008 Feb; 151(2):97-109. PMID: 18201677.
      View in: PubMed
    78. Walker AP, Tucker DC, Hall MA, Lohman K, Harrison H, Harrison BW, Reiss J, Acton RT, Adams PC, Diaz S, Holup J, Thomson E, Ellis SD, McLaren CE. Results communication and patient education after screening for possible hemochromatosis and iron overload: experience from the HEIRS Study of a large ethnically and linguistically diverse group. Genet Med. 2007 Nov; 9(11):778-91. PMID: 18007147.
      View in: PubMed
    79. Hall MA, Barton JC, Adams PC, McLaren CE, Reiss JA, Castro O, Ruggiero A, Acton RT, Power TE, Bent TC. Genetic screening for iron overload: No evidence of discrimination at 1 year. J Fam Pract. 2007 Oct; 56(10):829-34. PMID: 17908514.
      View in: PubMed
    80. Wenzel LB, Anderson R, Tucker DC, Palla S, Thomson E, Speechley M, Harrison H, Lewis-Jack O, Fadojutimi-Akinsiku M, Eckfeldt JH, Reiss JA, Rivers CA, Bookman E, Snively BM, McLaren CE. Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study. Genet Med. 2007 Oct; 9(10):705-12. PMID: 18073584.
      View in: PubMed
    81. McLaren CE, Barton JC, Gordeuk VR, Wu L, Adams PC, Reboussin DM, Speechley M, Chang H, Acton RT, Harris EL, Ruggiero AM, Castro O. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. Am J Hematol. 2007 Oct; 82(10):898-905. PMID: 17597476.
      View in: PubMed
    82. Acton RT, Snively BM, Barton JC, McLaren CE, Adams PC, Rich SS, Eckfeldt JH, Press RD, Sholinsky P, Leiendecker-Foster C, McLaren GD, Speechley MR, Harris EL, Dawkins FW, Gordeuk VR. A genome-wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family Study. Clin Genet. 2007 Jun; 71(6):518-29. PMID: 17539901.
      View in: PubMed
    83. Harris EL, McLaren CE, Reboussin DM, Gordeuk VR, Barton JC, Acton RT, McLaren GD, Vogt TM, Snively BM, Leiendecker-Foster C, Holup JL, Passmore LV, Eckfeldt JH, Lin E, Adams PC. Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med. 2007 Apr 09; 167(7):722-6. PMID: 17420432.
      View in: PubMed
    84. Thomson A, Tye-Din J, Tonga S, Scott J, McLaren C, Pavli P, Lomas F. Aspiration in the context of upper gastrointestinal endoscopy. Can J Gastroenterol. 2007 Apr; 21(4):223-5. PMID: 17431510.
      View in: PubMed
    85. Dawkins FW, Gordeuk VR, Snively BM, Lovato L, Barton JC, Acton RT, McLaren GD, Leiendecker-Foster C, McLaren CE, Adams PC, Speechley M, Harris EL, Jackson S, Thomson EJ. African Americans at risk for increased iron stores or liver disease. Am J Med. 2007 Aug; 120(8):734.e1-9. PMID: 17679134.
      View in: PubMed
    86. Rivers CA, Barton JC, Gordeuk VR, Acton RT, Speechley MR, Snively BM, Leiendecker-Foster C, Press RD, Adams PC, McLaren GD, Dawkins FW, McLaren CE, Reboussin DM. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis. 2007 May-Jun; 38(3):247-52. PMID: 17276706.
      View in: PubMed
    87. Steiner M, Leiendecker-Foster C, McLaren GD, Snively BM, McLaren CE, Adams PC, Eckfeldt JH. Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A in North American Vietnamese with and without phenotypic evidence of iron overload. Transl Res. 2007 Feb; 149(2):92-5. PMID: 17240320.
      View in: PubMed
    88. Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening. Genet Test. 2007; 11(3):269-75. PMID: 17949288.
      View in: PubMed
    89. McLaren CE, Li KT, McLaren GD, Gordeuk VR, Snively BM, Reboussin DM, Barton JC, Acton RT, Dawkins FW, Harris EL, Eckfeldt JH, Moses GC, Adams PC. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload. Transl Res. 2006 Oct; 148(4):196-206. PMID: 17002922.
      View in: PubMed
    90. Gastañaga VM, McLaren CE, Delfino RJ. Power calculations for generalized linear models in observational longitudinal studies: a simulation approach in SAS. Comput Methods Programs Biomed. 2006 Oct; 84(1):27-33. PMID: 16982112.
      View in: PubMed
    91. Schwindt CD, Tjoa T, Floro JN, McLaren C, Delfino RJ. Association of atopy to asthma severity and medication use in children. J Asthma. 2006 Aug; 43(6):439-46. PMID: 16952862.
      View in: PubMed
    92. Holcombe RF, McLaren CE, Milovanovic T. Immunomodulation with low dose levamisole in patients with colonic polyps. Cancer Detect Prev. 2006; 30(1):94-8. PMID: 16458451.
      View in: PubMed
    93. Acton RT, Barton JC, Snively BM, McLaren CE, Adams PC, Harris EL, Speechley MR, McLaren GD, Dawkins FW, Leiendecker-Foster C, Holup JL, Balasubramanyam A. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis. 2006; 16(4):815-21. PMID: 17061732.
      View in: PubMed
    94. Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study. Clin Genet. 2006 Jan; 69(1):48-57. PMID: 16451136.
      View in: PubMed
    95. Su MY, Yu HJ, Carpenter PM, McLaren CE, Nalcioglu O. Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients. Technol Cancer Res Treat. 2005 Jun; 4(3):255-63. PMID: 15896081.
      View in: PubMed
    96. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005 Apr 28; 352(17):1769-78. PMID: 15858186.
      View in: PubMed
    97. Adams PC, Reboussin DM, Leiendecker-Foster C, Moses GC, McLaren GD, McLaren CE, Dawkins FW, Kasvosve I, Acton RT, Barton JC, Zaccaro D, Harris EL, Press R, Chang H, Eckfeldt JH. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study. Clin Chem. 2005 Jun; 51(6):1048-52. PMID: 15833784.
      View in: PubMed
    98. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test. 2005; 9(3):231-41. PMID: 16225403.
      View in: PubMed
    99. Carpenter PM, Linden KG, McLaren CE, Li KT, Arain S, Barr RJ, Hite P, Sun JD, Meyskens FL. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):1996-2002. PMID: 15598753.
      View in: PubMed
    100. Shibuya TY, Kim S, Nguyen K, Do J, McLaren CE, Li KT, Chen WP, Parikh P, Wadhwa A, Zi X, Chen VY, Wong HS, Armstrong WB, Yoo GH. Bioactive suture: a novel immunotherapy for head and neck cancer. Clin Cancer Res. 2004 Oct 15; 10(20):7088-99. PMID: 15501989.
      View in: PubMed
    101. Delfino RJ, Quintana PJ, Floro J, Gastañaga VM, Samimi BS, Kleinman MT, Liu LJ, Bufalino C, Wu CF, McLaren CE. Association of FEV1 in asthmatic children with personal and microenvironmental exposure to airborne particulate matter. Environ Health Perspect. 2004 Jun; 112(8):932-41. PMID: 15175185.
      View in: PubMed
    102. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging. 2003 Oct; 18(4):467-77. PMID: 14508784.
      View in: PubMed
    103. McLaren CE, Li KT, Garner CP, Beutler E, Gordeuk VR. Mixture distribution analysis of phenotypic markers reflecting HFE gene mutations. Blood. 2003 Dec 15; 102(13):4563-6. PMID: 12907432.
      View in: PubMed
    104. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, Reboussin DM, McLaren GD, Sholinsky P, Walker AP, Gordeuk VR, Leiendecker-Foster C, Dawkins FW, Eckfeldt JH, Mellen BG, Speechley M, Thomson E. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci. 2003 Feb; 325(2):53-62. PMID: 12589228.
      View in: PubMed
    105. Linden KG, Carpenter PM, McLaren CE, Barr RJ, Hite P, Sun JD, Li KT, Viner JL, Meyskens FL. Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea. Recent Results Cancer Res. 2003; 163:165-71; discussion 264-6. PMID: 12903852.
      View in: PubMed
    106. Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol. 2002 Oct; 87(1):8-16. PMID: 12468336.
      View in: PubMed
    107. Delfino RJ, Zeiger RS, Seltzer JM, Street DH, McLaren CE. Association of asthma symptoms with peak particulate air pollution and effect modification by anti-inflammatory medication use. Environ Health Perspect. 2002 Oct; 110(10):A607-17. PMID: 12361942.
      View in: PubMed
    108. Ahlering TE, Skarecky DW, McLaren CE, Weinberg AC. Seminal vesicle involvement in patients with D1 disease predicts early prostate specific antigen recurrence and metastasis after radical prostatectomy and early androgen ablation. Cancer. 2002 Mar 15; 94(6):1648-53. PMID: 11920524.
      View in: PubMed
    109. Shibuya TY, Nugyen N, McLaren CE, Li KT, Wei WZ, Kim S, Yoo GH, Rogowski A, Ensley J, Sakr W. Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res. 2002 Mar; 8(3):745-51. PMID: 11895904.
      View in: PubMed
    110. McLaren CE, Li KT, Gordeuk VR, Hasselblad V, McLaren GD. Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. Blood. 2001 Oct 15; 98(8):2345-51. PMID: 11588029.
      View in: PubMed
    111. Doyle KJ, McLaren CE, Shanks JE, Galus CM, Meyskens FL. Effects of difluoromethylornithine chemoprevention on audiometry thresholds and otoacoustic emissions. Arch Otolaryngol Head Neck Surg. 2001 May; 127(5):553-8. PMID: 11346432.
      View in: PubMed
    112. Mehta RS, Bornstein R, Yu IR, Parker RJ, McLaren CE, Nguyen KP, Li KT, Fruehauf JP. Breast cancer survival and in vitro tumor response in the extreme drug resistance assay. Breast Cancer Res Treat. 2001 Apr; 66(3):225-37. PMID: 11510694.
      View in: PubMed
    113. Suriano KA, McHale M, McLaren CE, Li KT, Re A, DiSaia PJ. Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol. 2001 Apr; 97(4):555-60. PMID: 11275027.
      View in: PubMed
    114. Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001 Mar; 120(4):848-56. PMID: 11231939.
      View in: PubMed
    115. Simoneau AR, Gerner EW, Phung M, McLaren CE, Meyskens FL. Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial. J Natl Cancer Inst. 2001 Jan 03; 93(1):57-9. PMID: 11136843.
      View in: PubMed
    116. Mehta R, Kyshtoobayeva A, Kurosaki T, Small EJ, Kim H, Stroup R, McLaren CE, Li KT, Fruehauf JP. Independent association of angiogenesis index with outcome in prostate cancer. Clin Cancer Res. 2001 Jan; 7(1):81-8. PMID: 11205922.
      View in: PubMed
    117. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000 Aug 03; 343(5):327-31. PMID: 10922422.
      View in: PubMed
    118. Janoff DM, Skarecky DW, McLaren CE, Ahlering TE. Prostate needle biopsy infection after four or six dose ciprofloxacin. Can J Urol. 2000 Aug; 7(4):1066-9. PMID: 11109076.
      View in: PubMed
    119. Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology. 2000 May; 31(5):1160-4. PMID: 10796893.
      View in: PubMed
    120. McLaren CE, Kambour EL, McLachlan GJ, Lukaski HC, Li X, Brittenham GM, McLaren GD. Patient-specific analysis of sequential haematological data by multiple linear regression and mixture distribution modelling. Stat Med. 2000 Jan 15; 19(1):83-98. PMID: 10623915.
      View in: PubMed
    121. Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 2000 Jan; 9(1):43-7. PMID: 10667462.
      View in: PubMed
    122. Mobley JE, Pollard RB, Schrader S, Adler MH, Kelleher T, McLaren C. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team. AIDS. 1999 Jul 30; 13(11):F87-93. PMID: 10449279.
      View in: PubMed
    123. Dolmans DE, Thuma PE, Mabeza GF, Biemba G, Parry D, McLaren CE, Gordeuk VR. A prospective study of combination antimalarial therapy and of anaemia in Zambian children with cerebral malaria. Ann Trop Med Parasitol. 1999 Jul; 93(5):527-31. PMID: 10690249.
      View in: PubMed
    124. Lacerda L, Arosa FA, Lacerda R, Cabeda J, Porto G, Amaral O, Fortuna A, Pinto R, Oliveira P, McLaren CE, Sá Miranda C, de Sousa M. T cell numbers relate to bone involvement in Gaucher disease. Blood Cells Mol Dis. 1999 Apr; 25(2):130-8. PMID: 10389595.
      View in: PubMed
    125. Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, Burt AD, Fleming KA. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med. 1998 Aug 13; 339(7):417-23. PMID: 9700174.
      View in: PubMed
    126. van der Torn M, Thuma PE, Mabeza GF, Biemba G, Moyo VM, McLaren CE, Brittenham GM, Gordeuk VR. Loading dose of quinine in African children with cerebral malaria. Trans R Soc Trop Med Hyg. 1998 May-Jun; 92(3):325-31. PMID: 9861410.
      View in: PubMed
    127. Gordeuk VR, McLaren CE, Looker AC, Hasselblad V, Brittenham GM. Distribution of transferrin saturations in the African-American population. Blood. 1998 Mar 15; 91(6):2175-9. PMID: 9490706.
      View in: PubMed
    128. Thuma PE, Mabeza GF, Biemba G, Bhat GJ, McLaren CE, Moyo VM, Zulu S, Khumalo H, Mabeza P, M'Hango A, Parry D, Poltera AA, Brittenham GM, Gordeuk VR. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hyg. 1998 Mar-Apr; 92(2):214-8. PMID: 9764337.
      View in: PubMed
    129. McLaren CE, McLachlan GJ, Halliday JW, Webb SI, Leggett BA, Jazwinska EC, Crawford DH, Gordeuk VR, McLaren GD, Powell LW. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology. 1998 Mar; 114(3):543-9. PMID: 9496946.
      View in: PubMed
    130. Moyo VM, Makunike R, Gangaidzo IT, Gordeuk VR, McLaren CE, Khumalo H, Saungweme T, Rouault T, Kiire CF. African iron overload and hepatocellular carcinoma (HA-7-0-080). Eur J Haematol. 1998 Jan; 60(1):28-34. PMID: 9451425.
      View in: PubMed
    131. Angelucci E, Giovagnoni A, Valeri G, Paci E, Ripalti M, Muretto P, McLaren C, Brittenham GM, Lucarelli G. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood. 1997 Dec 15; 90(12):4736-42. PMID: 9389689.
      View in: PubMed
    132. McLaren CE. Mixture models in haematology: a series of case studies. Stat Methods Med Res. 1996 Jun; 5(2):129-53. PMID: 8817795.
      View in: PubMed
    133. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel G, Bothwell TH. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood. 1996 Apr 15; 87(8):3470-6. PMID: 8605366.
      View in: PubMed
    134. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edwards CQ, Griffen LM, Kushner JP, Brittenham GM. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 1995 Sep 01; 86(5):2021-7. PMID: 7655030.
      View in: PubMed
    135. Gordeuk VR, Thuma PE, McLaren CE, Biemba G, Zulu S, Poltera AA, Askin JE, Brittenham GM. Transferrin saturation and recovery from coma in cerebral malaria. Blood. 1995 Jun 01; 85(11):3297-301. PMID: 7756663.
      View in: PubMed
    136. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994 Sep 01; 331(9):567-73. PMID: 8047080.
      View in: PubMed
    137. Harris JW, Danish EH, Brittenham GM, McLaren CE. Pyridoxine responsive hereditary sideroblastic erythropoiesis and iron overload: two microcytic subpopulations in the affected male, one normocytic and one microcytic subpopulation in the obligate female carrier. Am J Hematol. 1993 Apr; 42(4):400-1. PMID: 8493994.
      View in: PubMed
    138. McLaren C, Rozencweig M, Beltangady M, Nicaise C, Yarchoan R, Dolin R, Allan JD, Cooley TP, Seidlin M, Smaldone LF. Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S32-9. PMID: 8425018.
      View in: PubMed
    139. Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, Young NS, Allen CJ, Farrell DE, Harris JW. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993 Jan; 42(1):81-5. PMID: 8416302.
      View in: PubMed
    140. Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med. 1992 Nov 19; 327(21):1473-7. PMID: 1406879.
      View in: PubMed
    141. Connolly KJ, Allan JD, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE. Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine. Am J Med. 1991 Nov; 91(5):471-8. PMID: 1659189.
      View in: PubMed
    142. McLaren CE, Wagstaff M, Brittenham GM, Jacobs A. Detection of two-component mixtures of lognormal distributions in grouped, doubly truncated data: analysis of red blood cell volume distributions. Biometrics. 1991 Jun; 47(2):607-22. PMID: 1912264.
      View in: PubMed
    143. Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. N Engl J Med. 1990 May 10; 322(19):1333-40. PMID: 2139173.
      View in: PubMed
    144. Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med. 1990 May 10; 322(19):1340-5. PMID: 2139174.
      View in: PubMed
    145. Chester CS, McLaren CE. Somatosensory evoked response and recovery from stroke. Arch Phys Med Rehabil. 1989 Jul; 70(7):520-5. PMID: 2742467.
      View in: PubMed
    146. Cohen DI, Breslau D, Porter DK, Goldberg HI, Hershey CO, Lee JC, McLaren CE. Academic group practice. The physicians' view. Med Care. 1987 Aug; 25(8):686-94. PMID: 3695671.
      View in: PubMed
    147. Overmoyer BA, McLaren CE, Brittenham GM. Uniformity of liver density and nonheme (storage) iron distribution. Arch Pathol Lab Med. 1987 Jun; 111(6):549-54. PMID: 3579513.
      View in: PubMed
    148. Goldberg HI, Cohen DI, Hershey CO, Hsiue IL, Porter DK, McLaren CE. A randomized controlled trial of academic group practice. Improving the operation of the medicine clinic. JAMA. 1987 Apr 17; 257(15):2051-5. PMID: 3560381.
      View in: PubMed
    149. McLaren CE, Brittenham GM, Hasselblad V. Statistical and graphical evaluation of erythrocyte volume distributions. Am J Physiol. 1987 Apr; 252(4 Pt 2):H857-66. PMID: 3565597.
      View in: PubMed
    150. Hershey CO, Dawson NV, McLaren CE, Siciliano CJ, Cohen DI. Resident knowledge of charges: are we asking the right questions? Am J Med Sci. 1987 Mar; 293(3):182-6. PMID: 3565464.
      View in: PubMed
    151. Hershey CO, Cohen DI, Goldberg HI, McLaren CE, Dawson NV, Siciliano C, Porter DK, Breslau D. Effect of an academic group practice on patient show rates: a randomized controlled trial. Med Care. 1987 Jan; 25(1):72-7. PMID: 3807448.
      View in: PubMed
    152. Cohen DI, Breslau D, Porter DK, Hershey CO, Goldberg HI, Dawson NV, Lee JC, McLaren CE. Academic group practice. The patient's perspective. Med Care. 1986 Nov; 24(11):990-8. PMID: 3773581.
      View in: PubMed
    153. Cohen DI, Breslau D, Porter DK, Goldberg HI, Dawson NV, Hershey CO, Lee JC, McLaren CE, Breslau N. The cost implications of academic group practice. A randomized controlled trial. N Engl J Med. 1986 Jun 12; 314(24):1553-7. PMID: 3713748.
      View in: PubMed
    154. Stassen WN, McCullough AJ, Bacon BR, Gutnik SH, Wadiwala IM, McLaren C, Kalhan SC, Tavill AS. Immediate diagnostic criteria for bacterial infection of ascitic fluid. Evaluation of ascitic fluid polymorphonuclear leukocyte count, pH, and lactate concentration, alone and in combination. Gastroenterology. 1986 May; 90(5 Pt 1):1247-54. PMID: 3956943.
      View in: PubMed
    155. McLaren CE, Brittenham GM, Hasselblad V. Analysis of the volume of red blood cells: application of the expectation-maximization algorithm to grouped data from the doubly-truncated lognormal distribution. Biometrics. 1986 Mar; 42(1):143-58. PMID: 3719051.
      View in: PubMed
    156. Gordeuk VR, Brittenham GM, McLaren CE, Hughes MA, Keating LJ. Carbonyl iron therapy for iron deficiency anemia. Blood. 1986 Mar; 67(3):745-52. PMID: 3947745.
      View in: PubMed
    157. Hershey CO, Tomford JW, McLaren CE, Porter DK, Cohen DI. The natural history of intravenous catheter-associated phlebitis. Arch Intern Med. 1984 Jul; 144(7):1373-5. PMID: 6732398.
      View in: PubMed
    158. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study. Arch Intern Med. 1984 Jun; 144(6):1191-4. PMID: 6375611.
      View in: PubMed
    159. Bacon BR, Brittenham GM, Tavill AS, McLaren CE, Park CH, Recknagel RO. Hepatic lipid peroxidation in vivo in rats with chronic dietary iron overload is dependent on hepatic iron concentration. Trans Assoc Am Physicians. 1983; 96:146-54. PMID: 6679952.
      View in: PubMed
    160. Sibrack CD, McLaren C, Barry DW. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy. Am J Med. 1982 Jul 20; 73(1A):372-5. PMID: 6285725.
      View in: PubMed
    161. McLaren C, Sibrack CD, Barry DW. Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolates. Am J Med. 1982 Jul 20; 73(1A):376-9. PMID: 6285726.
      View in: PubMed
    162. Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med. 1982 Mar; 96(3):265-9. PMID: 7036816.
      View in: PubMed
    163. Hargreaves RM, Street M, Hoy T, Jacobs A, McLaren C. Myoglobin depletion in childhood iron deficiency. Br J Haematol. 1981 Mar; 47(3):399-401. PMID: 7459277.
      View in: PubMed
    164. McLaren C, Pope B. Macrophage dependency of in vitro B cell response to influenza virus antigens. J Immunol. 1980 Dec; 125(6):2679-84. PMID: 6968792.
      View in: PubMed
    165. Worwood M, Cragg SJ, Jacobs A, McLaren C, Ricketts C, Economidou J. Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload. Br J Haematol. 1980 Nov; 46(3):409-16. PMID: 7448126.
      View in: PubMed
    166. Schneider AJ, Knoke JD, Zollinger RM, McLaren CE, Baetz WR. Morbidity prediction using pre- and intraoperative data. Anesthesiology. 1979 Jul; 51(1):4-10. PMID: 453591.
      View in: PubMed
    167. Jennings R, Potter CW, McLaren C. Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines. J Immunol. 1974 Dec; 113(6):1834-43. PMID: 4547776.
      View in: PubMed